Skip to content

News Health

Health News, Tips, and More

Menu
  • Disclaimer
  • Related Sites
Menu

Pharmaceuticals presentated additional fidaxomicin phase

Posted on September 6, 2010September 3, 2010 by News Health

Results from studies related to Optimer Pharmaceuticals, Inc.’s (Nasdaq: OPTR) lead developmental product candidate, fidaxomicin, will be presented at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) to be held at the Boston Convention and Exhibition Center in Boston on September 12-15, 2010.

Fidaxomicin abstracts and speakers include:

“Randomized Controlled Trial (RCT) of Fidaxomicin (FDX) Versus Vancomycin (VAN) in Treatment of Recurrent Clostridium difficile Infection (CDI)”

Oral Presentation: Oliver Cornely, M.D.

Tuesday, September 14, 2010 9:00 am – 9:15 am Eastern Time

Presentation number: L1-1305 in 253A

“Clostridium difficile Strain Type as Determined by Restriction Endonuclease Analysis (REA) Typing in Two Phase III Trials of Fidaxomicin vs Vancoymcin: Treatment Outcome for the Epidemic BI/NAP1/027 Strain”

Oral Presentation: Dale N. Gerding, M.D.

Tuesday, September 14, 2010 9:15 am – 9:30 am Eastern Time

Presentation number: L1-1306 in 253A

“Correlation of the ATLAS Bedside Scoring System And Its Components With Cure and Recurrence of Clostridium difficile Infection (CDI)”

Poster Presentation: Mark A. Miller, M.D.

Tuesday, September 14, 2010 11:15 am – 1:15 pm Eastern Time

Presentation number: K-1692 in Exhibit Hall B1

“Use of Concomitant Antibiotics (CA) Has a Deleterious Effect on Outcomes During Treatment for Clostridium difficile Infection (CDI)”

Poster Presentation: Kate Mullane, M.D.

Tuesday, September 14, 2010 11:15 am – 1:15 pm Eastern Time

Presentation number: K-1695 in Exhibit Hall B1

“Comparative Susceptibilities of Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence and Failure from Patients in a Phase III trial (004) of C difficile infection (CDI)”.

Poster Presentation: Ellie J. Goldstein, M.D.

Tuesday, September 14, 2010 11:15 am – 1:15 pm Eastern Time

Presentation number: K-1691 in Exhibit Hall B1

Source: http://www.medicalnewstoday.com/articles/199868.php

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Answering Your Questions About Alcohol Rehab
  • 8 Key Home and Personal Hygiene Goals and Objectives for 2023
  • The Importance of Cell and Gene Therapy
  • 9 Ways to Optimize Your Health This Year
  • Healthful Living Resources and Services
  • How to Lose Weight After Many Failed Attempts
  • Tips to Successfully Utilize Telehealth Services
  • How to Keep Your Older Relatives Healthy
  • The Most Physically Demanding Trades That Require Employee Physical Fitness
  • Living a Healthy Lifestyle Tips for Your Home

Archives

March 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Feb    
© 2023 News Health | Powered by Superbs Personal Blog theme